/MOH
MOH Stock - Molina Healthcare, Inc.
Healthcare|Medical - Healthcare PlansNYSE
$163.69+0.60%
+$0.97 (+0.60%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).75
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+12.6%upside
Target: $184.31
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MOH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$162.05 – $165.33
TARGET (TP)$184.27
STOP LOSS$150.59
RISK/REWARD1:1.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.52
52W High$359.97
52W Low$133.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B |
| Gross Profit | $4.74B | $4.33B | $3.93B | $3.28B | $2.68B |
| Gross Margin | 11.7% | 12.7% | 12.3% | 11.8% | 13.8% |
| Operating Income | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B |
| Net Income | $1.18B | $1.09B | $792.00M | $659.00M | $673.00M |
| Net Margin | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% |
| EPS | $20.52 | $18.71 | $13.70 | $11.40 | $11.41 |
Company Overview
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
13%
Hold / Neutral
12
75%
Sell / Underperform
2
13%
Analyst Consensus🔴 Bearish
2 Bullish14 Neutral/Bearish
Price Targets
$326
Average Target
↑ 99.1% Upside
Now
$144
Low
$326
Average
$439
High
Based on 21 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 24th 2025 | Barclays | Downgrade | Underweight | $144 |
| October 16th 2025 | TD Cowen | Downgrade | Hold | $203 |
| October 14th 2025 | Goldman | Initiation | Neutral | $207 |
| July 25th 2025 | Cantor Fitzgerald | Downgrade | Neutral | $210 |
| July 25th 2025 | Truist | Downgrade | Hold | $180 |
| July 10th 2025 | Morgan Stanley | Downgrade | Equal Weight | $266 |
| June 9th 2025 | Morgan Stanley | Initiation | Overweight | $364 |
| April 22nd 2025 | Bernstein | Initiation | Outperform | $414 |
| April 15th 2025 | Robert W. Baird | Downgrade | Neutral | $375 |
| March 5th 2025 | Wells Fargo | Upgrade | Overweight | $372← $295 |
| December 17th 2024 | JP Morgan | Resumed | Neutral | $350← $378 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $405 |
| March 28th 2024 | BofA Securities | Downgrade | Underperform | $439 |
| March 6th 2024 | Barclays | Initiation | Equal Weight | $437 |
| February 15th 2024 | Wells Fargo | Upgrade | Equal Weight | $420← $367 |
Earnings History & Surprises
MOHBeat Rate
83%
Last 18 quarters
Avg Surprise
-0.3%
EPS vs Estimate
Beats / Misses
15/3
Last 12 quarters
Latest EPS
$1.84
Q4 2025
EPS Surprise History
Q1 24
+0.7%
$4.38vs$4.35
Q2 24
+2.5%
$5.73vs$5.59
Q3 24
+6.5%
$5.86vs$5.50
Q4 24
+3.4%
$6.01vs$5.81
Q1 25
-12.0%
$5.05vs$5.74
Q2 25
+1.8%
$6.08vs$5.97
Q3 25
-2.5%
$5.48vs$5.62
Q4 25
-53.7%
$1.84vs$3.97
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.43 | — | — | — |
Q4 2025 | Oct 22, 2025 | $3.97 | $1.84 | -53.7% | ✗ MISS |
Q3 2025 | Jul 23, 2025 | $5.62 | $5.48 | -2.5% | ✗ MISS |
Q2 2025 | Apr 23, 2025 | $5.97 | $6.08 | +1.8% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $5.74 | $5.05 | -12.0% | ✗ MISS |
Q4 2024 | Oct 23, 2024 | $5.81 | $6.01 | +3.4% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $5.50 | $5.86 | +6.5% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $5.59 | $5.73 | +2.5% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $4.35 | $4.38 | +0.7% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $4.88 | $5.05 | +3.5% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $5.10 | $5.65 | +10.8% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $5.12 | $5.81 | +13.5% | ✓ BEAT |
Q1 2023 | Feb 8, 2023 | $4.06 | $4.10 | +1.0% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $4.21 | $4.36 | +3.6% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $4.29 | $4.55 | +6.1% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $4.66 | $4.90 | +5.2% | ✓ BEAT |
Q1 2022 | Feb 9, 2022 | $2.82 | $2.88 | +2.1% | ✓ BEAT |
Q4 2021 | Oct 27, 2021 | $2.79 | $2.83 | +1.4% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $3.38 | $3.40 | +0.6% | ✓ BEAT |
Latest News
President Trump Says We Could Get Insurance Companies To Cut Prices To Stay In System; I Will Call Meeting Of Insurance Companies To Get Their Price Down; Meeting In Coming Weeks
📈 PositiveBenzinga•Dec 19, 2025, 08:03 PM•Also: , ,
Shares of healthcare stocks are trading higher amid the Republican healthcare bill failing to win enough votes to advance in the Senate.
📈 PositiveBenzinga•Dec 11, 2025, 07:46 PM•Also: , ,
Reuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeBenzinga•Nov 24, 2025, 07:22 PM•Also: , ,
Shares of healthcare stocks are trading higher after Politico reported the White House will propose a two-year extension of Obamacare subsidies with new limits on eligibility.
📈 PositiveBenzinga•Nov 24, 2025, 01:00 PM•Also: , ,
Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBenzinga•Nov 24, 2025, 11:16 AM•Also: , ,
Reported Earlier, Molina Healthcare Prices $850M Of 6.500% Senior Notes Due 2031 For General Corporate Purposes And Loan Repayment
➖ NeutralBenzinga•Nov 18, 2025, 07:22 AM
Molina Healthcare Announces Proposed Offering Of $750M Senior Notes Due 2031
➖ NeutralBenzinga•Nov 17, 2025, 01:20 PM
Molina Healthcare Awarded Contract By Florida Agency For Health Care Administration To Offer Medicaid Managed Care Program And Children's Health Insurance Program In State
📈 PositiveBenzinga•Nov 14, 2025, 02:02 PM
Shares of health insurers are trading higher amid a possible rebound after President Trump recently proposed that healthcare funding should go directly to people. On Monday, the Senate passed its shutdown-ending bill that lacked a provision to extend Obamacare subsidies; however, the Democrats secured a commitment to vote on credits in December.
📈 PositiveBenzinga•Nov 12, 2025, 05:44 PM•Also: , ,
Wells Fargo Maintains Overweight on Molina Healthcare, Lowers Price Target to $165
➖ NeutralBenzinga•Nov 12, 2025, 03:20 PM
Shares of healthcare stocks are trading lower after the US Senate approved a deal clearing the path to ending the government shutdown. The deal does not include an extension of expiring Affordable Care Act subsidies
📉 NegativeBenzinga•Nov 10, 2025, 04:12 PM•Also: , ,
Goldman Sachs Maintains Neutral on Molina Healthcare, Lowers Price Target to $167
➖ NeutralBenzinga•Oct 24, 2025, 05:48 PM
UBS Maintains Neutral on Molina Healthcare, Lowers Price Target to $170
➖ NeutralBenzinga•Oct 24, 2025, 03:27 PM•Also:
Cantor Fitzgerald Maintains Neutral on Molina Healthcare, Lowers Price Target to $180
➖ NeutralBenzinga•Oct 24, 2025, 01:43 PM•Also:
Barclays Downgrades Molina Healthcare to Underweight, Lowers Price Target to $144
📉 NegativeBenzinga•Oct 24, 2025, 10:37 AM•Also: ,
Benzinga Market Summary: S&P Moves Higher, Oil Surges On US-Russia Sanctions, Molina Healthcare Falls On Weak Guidance
➖ NeutralBenzinga•Oct 23, 2025, 06:37 PM•Also: , ,
Molina Healthcare shares are trading lower after the company issued FY2025 EPS guidance below expectations.
📉 NegativeBenzinga•Oct 23, 2025, 01:00 PM
Shares of health insurers are trading lower after Molina Healthcare issued FY2025 adjusted EPS guidance below expectations.
📉 NegativeBenzinga•Oct 23, 2025, 12:56 PM
Molina drops as it cuts 2025 full-year earnings guidance
📉 NegativeSeeking Alpha•Oct 22, 2025, 09:04 PM
Centene shares are trading lower. The stock may be experiencing weakness amid sympathy with Molina Healthcare after the company issued FY25 adjusted EPS guidance below expectations.
📉 NegativeBenzinga•Oct 22, 2025, 08:54 PM•Also:
Frequently Asked Questions about MOH
What is MOH's current stock price?
Molina Healthcare, Inc. (MOH) is currently trading at $163.69 per share. The stock has moved +0.60% today.
What is the analyst price target for MOH?
The average analyst price target for MOH is $184.27, based on 1 analyst.
What sector is Molina Healthcare, Inc. in?
Molina Healthcare, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NYSE exchange.
What is MOH's market cap?
Molina Healthcare, Inc. has a market capitalization of $8.87 billion, making it a mid-cap company.
Does MOH pay dividends?
No, Molina Healthcare, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATR
AptarGroup, Inc.
$121.39
Mkt Cap: $8.0B
AVTR
Avantor, Inc.
$11.27
Mkt Cap: $7.7B
BIO
Bio-Rad Laboratories, Inc.
$301.53
Mkt Cap: $8.1B
DVA
DaVita Inc.
$115.20
Mkt Cap: $8.1B
GMED
Globus Medical, Inc.
$87.06
Mkt Cap: $11.7B
GRFS
Grifols, S.A.
$9.02
Mkt Cap: $7.6B
HALO
Halozyme Therapeutics, Inc.
$67.35
Mkt Cap: $7.9B
HQY
HealthEquity, Inc.
$95.50
Mkt Cap: $8.3B
HSIC
Henry Schein, Inc.
$77.35
Mkt Cap: $9.5B
MASI
Masimo Corporation
$134.04
Mkt Cap: $7.2B
Explore stocks similar to MOH for comparison